A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
about
Novel treatment strategies in triple-negative breast cancer: specific role of poly(adenosine diphosphate-ribose) polymerase inhibitionBRCA genetic screening in Middle Eastern and North African: mutational spectrum and founder BRCA1 mutation (c.798_799delTT) in North AfricanPathogenic variant burden in the ExAC database: an empirical approach to evaluating population data for clinical variant interpretation.Transcriptional profiling and dynamical regulation analysis identify potential kernel target genes of SCYL1-BP1 in HEK293T cells.BRCA1 and BRCA2 mutations in ethnic Lebanese Arab women with high hereditary risk breast cancer.Validation of an NGS Approach for Diagnostic BRCA1/BRCA2 Mutation Testing.BRCA1 and BRCA2 mutations in Iranian breast cancer patients: A systematic reviewThe frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from UkraineDouble Heterozygosity of BRCA2 and STK11 in Familial Breast Cancer Detected by Exome SequencingHaplotype analysis of BRCA1 intragenic markers in Iranian patients with familial breast and ovarian cancerPARP inhibitors: review of mechanisms of action and BRCA1/2 mutation targeting.Mismatch repair genes founder mutations and cancer susceptibility in Lynch syndrome.Disparities in breast cancer and african ancestry: a global perspective.Triple-Negative Breast Cancer in Ghanaian Women: The Korle Bu Teaching Hospital Experience.Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions.Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.SNM1B/Apollo in the DNA damage response and telomere maintenanceGenetics in an isolated population like Finland: a different basis for genomic medicine?Pedigree and BRCA gene analysis in breast cancer patients to identify hereditary breast and ovarian cancer syndrome to prevent morbidity and mortality of disease in Indian population.Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India.Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer.Breast Cancer Disparities: Socioeconomic Factors versus Biology.Breast cancer in Africa: prevalence, treatment options, herbal medicines, and socioeconomic determinants.Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan.Role of BRCA Mutations in the Modulation of Response to Platinum Therapy.New variants in the BRCA1 gene in Buryat Mongol breast cancer patients: Report from two families.Comparison between CaGene 5.1 and 6.0 for BRCA1/2 mutation prediction: a retrospective study of 150 BRCA1/2 genetic tests in 517 families with breast/ovarian cancer.Mutation analysis of BRCA1/2 mutations with special reference to polymorphic SNPs in Indian breast cancer patients.BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso
P2860
Q26851765-72FB995F-49DC-4735-B958-6BBD530D314EQ27002334-75E988C7-7AE0-4FD5-8440-CF13FF854C68Q31159863-8BAC450A-F440-44C0-B3BD-C5118DC81955Q34263334-A3D4F309-3453-4C0B-BBDD-70167D6E2F91Q35345684-A70ED94C-A80A-4323-AD80-C7153DBCB68DQ35609850-2B91BE94-69FB-4F5F-971C-88BDFB8D34B1Q35744834-43E8C153-3608-45E4-BA22-C33C45D16C0FQ36161162-22923474-5CBD-4F51-92BB-B9F187EB726CQ36279255-2514F7AF-04B3-4181-B166-A8EB6F78A10DQ37032901-5023CBEA-09CD-4A54-BA90-88EA738736CDQ37668511-58710E63-8E49-4E2A-8F1A-C7247AC44CDCQ38262826-41C342B6-A480-4272-A948-725AFF56EE1DQ38339360-A00D3D44-DA89-416A-9108-D3337BC06A35Q38411443-6831E66B-CDDD-4704-B0A2-6637EBC8C365Q38633504-0A238AB4-5BD7-48AC-9411-BBCE2B87799EQ38691342-CEE3990C-266B-4445-94E7-7AD7C5CB14F3Q39254699-E1C27860-2431-4167-9FE5-825F67048718Q39449815-58818C48-D14A-44D1-B4F7-1CA8FE9276C9Q40321595-A6369412-21E2-492F-A029-910220E7F1F7Q40890323-05700A60-2B12-41F7-A919-18F04A48FE76Q41696477-C3AA32E9-6388-47B5-B3AB-523114DF6E64Q46795876-EF9E2F0D-BD57-441E-AE75-74F6E78B7FE7Q48292951-E77A4E41-02F2-478A-A02B-BC67D4203517Q49573714-5F4EF4D7-8110-4A53-9997-858C39A97FA9Q49829001-4D808381-0E35-4544-908C-FA5B1C2B942FQ51257152-EC4E934A-4F3B-409E-B1E3-38DADD3926A6Q51280306-7000FEB8-0670-4FF0-9FE8-21F183970B1DQ55085561-9A05CFDC-A1E9-4F11-B6EE-44293811262FQ56335931-21DB0D07-050E-4C41-99A6-23A89E706CBC
P2860
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
@en
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
@nl
type
label
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
@en
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
@nl
prefLabel
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
@en
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
@nl
P2860
P921
P356
P1476
A comprehensive focus on global spectrum of BRCA1 and BRCA2 mutations in breast cancer.
@en
P2093
Fatemeh Karami
Parvin Mehdipour
P2860
P304
P356
10.1155/2013/928562
P407
P5008
P577
2013-11-07T00:00:00Z